Signed in as:
filler@godaddy.com
Todd Plutchok DC, CSCS
The CardioMetaboliQ Index is an informational overview that presents a proprietary weighted-risk assessment; providing patients a consolidated view of their overall wellness.
Lawrence R. O’Connor MD
David M. Marquis DC, DACBN
When it comes down to providing value for hard-earned healthcare dollars, the CardioMetaboliQ test and Health Report delivers.
By combining Fatty Liver Index, multiple residual heart risk markers, atherogenic index of plasma and anthropometric insulin resistance assessment with inflammation, oxidative stress and visceral adiposity measurements, CardioMetaboliQ provides a level of utility, scope and value to the user that is truly unique.
Most blood panels include liver function markers ALT and AST. These markers are actually not optimal in assessing Fatty Liver. Kotronen A et al, (2009)* demonstrated that as many as 80% of subjects with Fatty Liver were not properly identified using ALT in assessment.
The Fatty Liver Index used in the CardioMetaboliQ test has been the gold standard for non-invasive Fatty Liver assessment since it was introduced in 2006. Because Fatty Liver significantly worsens cardiovascular, metabolic and many other diseases, getting timely, accurate assessment is vital.
Integrative practitioners continuously strive to deliver value to clients. Value requires providing actionable, evidence-based information to patients in a way that is easy to interpret and absorb.
As an in-home, comprehensive blood spot test, CardioMetaboliQ gives patients unmatched value in assessing and addressing cardiovascular, hepatic, metabolic and cerebrovascular health. And it does all this in the comfort of the patients home, at an affordable price.
So often, test results are delivered as a pile of data. Those that need the information most, the patients, commonly feel overwhelmed and unable to parse the important meaning contained within.
The CardioMetaboliQ Health Report is a carefully designed hybrid report; containing nuanced and comprehensive information, but presented so the non-technical reader can get the salient facts about their health.
From the all-in-one CardioMetaboliQ Index, to the CardioMetaboliQ-10 best steps for success, the Health Report is a valuable, dynamic document. The BioCalculators further allow users to track and understand their personal focus and progress areas.
Clarity is critical. CardioMetaboliQ keeps that in mind with the CardioMetaboliQ Index, a single risk-averaged composite score that combines 10 critical markers from the Health Report.
Because liver, metabolic, and cardiovascular factors are all involved in cardiometabolic health, we provide a single data point that reflects an aggregate relative risk across the entire cardiometabolic health spectrum.
Note: the CardioMetaboliQ Index is for informational use only.
In the past, heart disease was largely thought to be driven by elevated LDL (“bad”) Cholesterol. Research now shows LDL to be just one of several factors in the atherogenic process, and not necessarily the major player. In fact, fully 50% of heart attacks occur in patients with “normal” LDL Cholesterol.
Research now shows that ”residual risk” factors including Remnant Cholesterol, Atherogenic Index, Inflammation, Oxidative Stress, Insulin Resistance and Fatty Liver represent a substantial portion of cardiovascular risk. A “heart health” test is incomplete without assessing residual risk factors.
Insulin Resistance (IR) is the cornerstone of cardiometabolic disease. CardioMetaboliQ assess the two most accurate IR values: a) the Triglyceride-Glucose Index (TyG) and b) TyG-WHtR which includes a Body Composition (anthropometric) factor for added sensitivity.
The Triglyceride-Glucose Index provides excellent relative risk data, mined from 4 decades of NHANES health data that allows for extensive prospective study, providing Insulin Resistance-based relative risk insights across numerous cardiovascular, hepatic (liver), neurocognitive and metabolic diseases.
The accuracy of the TyG is shown to surpass other IR markers, including the most widely referenced HOMA-IR and TG/HDL. And adding Body Composition (WHtR) improves accuracy across various genetic body composition phenotypes.
We know that receiving your test results is just the beginning. At CardioMetaboliQ we focus on giving users the tools for what comes after testing. Our BioCalculator and Research sections provide excellent tools for your next steps. Registered practitioners may access these tools on this website.
For non-practitioners, please access the BioCalculators and Research sections on our sister website Subscriber section located at CMIQ Research.
The BioCalculators allow users to examine their results and adjust the parameters and values to determine what changes they can make to reduce risks. The subscriber area also contains curated research that allows user to further their understanding about cardiometabolic health and wellness.
Re your kit online at register.cardiometaboliq.com as soon as you receive it, following the instructions included with the kit. Just log in and answer a few simple questions, enter the barcode ID number on your lab kit, measure your waist with the enclosed tape measure and you’re all set!
Carefully review and follow the instructions to prepare and then deposit blood drops onto the ADX100 card. Let the sample dry, make sure to write identifier information on the sample and pop everything into the prepaid USPS Priority Mail envelop. Your Health Report will be ready in a few days!
Place the sample card into the white foil ziploc pouch it came in, place the pouch into the padded return addressed envelope and pop it in any USPS Mail Box. Your CardioMetaboliQ Health Report will be ready for you in 6-8 business days!
Fatty Liver affects over 100 Million people in the US, worsening many diseases, including heart disease, kidney disease and diabetes.
Basic liver enzymes (ALT, AST) miss up to 80% of Fatty Liver cases.
Fatty Liver Index (FLI) is superior in assessing Fatty Liver. Only CardioMetaboliQ provides the Fatty Liver Index. Find out more about your liver health today.
Current research has determined that Insulin Sensitivity/Resistance is the cornerstone in cardiometabolic health and disease.
Peer-reviewed published literature confirms TyG and TyG-WHtR as superior to HOMA-IR, TG/HDL and several other IR indicators
CardioMetaboliQ is the only test that reports these critical and well validated TyG and TyG-WHtR index values.
Cardiovascular research now acknowledges that LDL Cholesterol fails to represent the full picture of cardiovascular risk.
“Residual Risk” markers like CRP, Remnant Cholesterol, Atherogenic Index and Triglyceride-Glucose Index, when assessed together, provide a more complete risk assessment than LDL alone.
CardioMetaboliQ is the only test to assess all of these critical indexes.
Apologies for the fine print, there’s just a lot to say when comparing CardioMetaboliQ to either the typical blood work at your annual check-up, or to home blood tests for Heart health etc. So zoom in and find out what makes CardioMetaboliQ such a great tool and an awesome value!
187 Calle Magdalena, Encinitas, California 92024, United States
Copyright © 2024 CardioMetaboliQ Labs LLC - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.